Benchmarking Point-of-Care Glucometers: A Comparative Study Using the Hexokinase Test and International Organization for Standardization (ISO) Standards

Introduction The International Diabetes Federation states that India accounts for one in seven of all adults with diabetes. Adherence to self-monitoring of blood glucose is essential for effective management of diabetes. Despite the wide variety of glucometers and their clinical applicability, there is a lot of ambiguity regarding their accuracy. Therefore, this study aimed to evaluate if three point-of-care glucometers using three different methods for the estimation of blood glucose fulfil the minimum accuracy needed by ISO15197:2013 when compared with the gold standard hexokinase test. Methods A cross-sectional study was conducted at two primary health care centers in Ernakulam district, which included 73 participants with diabetes and 73 without diabetes. We evaluated three different enzymes in the test glucometers: glucose dehydrogenase with pyrroloquinoline quinone (GDH-PQQ), glucose dehydrogenase with flavin adenine dinucleotide (GDH-FAD), and glucose oxidase (GOD). The glucometer readings were compared with the gold standard hexokinase test and ISO15197:2013 standards. To compare the accuracy of each glucometer with the reference method, the Bland-Altman plot was used and to evaluate the clinical significance of the differences between the glucometer and reference value the Clarke error grid analysis was performed. Results When compared with the gold standard hexokinase result, only 78.08% (GOD), 92.4% (GDH-PQQ), and 95.8 (GDH-FAD) of results were within the limits stipulated by ISO15197:2013. All three glucometers showed blood glucose results within zones A and B of the consensus error grid, implying that it is clinically acceptable, and the Bland-Altman plot showed that the GDH-FAD method had the narrowest range between the upper and lower limit of agreement and a minimum bias of -0.89. Conclusion Only one test glucometer with the GDH-FAD method met the ISO15197:2013 criteria. Glucometers must meet the accuracy standards for the safety of the patients.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2024-10-07
DOI
https://doi.org/10.7759/cureus.70981
Citations
3
Primary Topic
Pancreatic function and diabetes
Type
article
Field-Weighted Citation Impact
1.72
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Benchmarking Point-of-Care Glucometers: A Comparative Study Using the Hexokinase Test and International Organization for Standardization (ISO) Standards

Aswathy Sreedevi, Haseena Kaladi Palliyalil, Shibin M Shaji, Vishakan Ajayakumar Sunanda et al.
3 citations
Cureus
Pancreatic function and diabetes
1.72
article

Benchmarking Point-of-Care Glucometers: A Comparative Study Using the Hexokinase Test and International Organization for Standardization (ISO) Standards

Aswathy Sreedevi, Haseena Kaladi Palliyalil, Shibin M Shaji, Vishakan Ajayakumar Sunanda, Sarah Joy, Kelita George
article en
3 citations

Abstract

Introduction The International Diabetes Federation states that India accounts for one in seven of all adults with diabetes. Adherence to self-monitoring of blood glucose is essential for effective management of diabetes. Despite the wide variety of glucometers and their clinical applicability, there is a lot of ambiguity regarding their accuracy. Therefore, this study aimed to evaluate if three point-of-care glucometers using three different methods for the estimation of blood glucose fulfil the minimum accuracy needed by ISO15197:2013 when compared with the gold standard hexokinase test. Methods A cross-sectional study was conducted at two primary health care centers in Ernakulam district, which included 73 participants with diabetes and 73 without diabetes. We evaluated three different enzymes in the test glucometers: glucose dehydrogenase with pyrroloquinoline quinone (GDH-PQQ), glucose dehydrogenase with flavin adenine dinucleotide (GDH-FAD), and glucose oxidase (GOD). The glucometer readings were compared with the gold standard hexokinase test and ISO15197:2013 standards. To compare the accuracy of each glucometer with the reference method, the Bland-Altman plot was used and to evaluate the clinical significance of the differences between the glucometer and reference value the Clarke error grid analysis was performed. Results When compared with the gold standard hexokinase result, only 78.08% (GOD), 92.4% (GDH-PQQ), and 95.8 (GDH-FAD) of results were within the limits stipulated by ISO15197:2013. All three glucometers showed blood glucose results within zones A and B of the consensus error grid, implying that it is clinically acceptable, and the Bland-Altman plot showed that the GDH-FAD method had the narrowest range between the upper and lower limit of agreement and a minimum bias of -0.89. Conclusion Only one test glucometer with the GDH-FAD method met the ISO15197:2013 criteria. Glucometers must meet the accuracy standards for the safety of the patients.

CureusVol. 16(10)
Amrita Institute of Medical Sciences and Research Centre (IN)
Partnerships for the goals
Openalex Percentile: Top 15%
Pancreatic function and diabetes
1.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.